Effects of taxane-induced peripheral neuropathy on hand dexterity impairment: evaluation of quantitative and subjective assessments.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
23 Apr 2024
Historique:
received: 12 09 2023
accepted: 14 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 23 4 2024
Statut: epublish

Résumé

Chemotherapy-induced peripheral neuropathy (CIPN) commonly involves hand dexterity impairment. However, the factors affecting hand dexterity impairment are unknown and there is currently no established treatment. The purpose of the current study was to clarify factors influencing hand dexterity impairment in taxane-induced peripheral neuropathy using subjective and objective assessments. We assessed patient characteristics, treatment-related factors, subjective symptoms of CIPN (Patient Neurotoxicity Questionnaire [PNQ]), psychological symptoms, and upper limb dysfunction (Quick Disabilities of the Arm, Shoulder and Hand [Quick DASH]). Quantitative assessments were pinch strength, sensory threshold, hand dexterity impairment, and grip force control. Multiple regression analysis was performed using hand dexterity impairment as the dependent variable and age and PNQ, Quick DASH, and control of grip force as independent variables. Forty-three breast cancer patients were included in the analysis. Hand dexterity impairment in taxane-induced peripheral neuropathy patients was significantly correlated with age, grip force control, and PNQ sensory scores (p < 0.008). Multiple regression analysis demonstrated that PNQ sensory scores and grip force control were significantly associated with hand dexterity impairment (p < 0.01). Subjective symptoms (numbness and pain) and grip force control contributed to impaired hand dexterity in taxane-induced peripheral neuropathy.

Identifiants

pubmed: 38652168
doi: 10.1007/s00520-024-08504-4
pii: 10.1007/s00520-024-08504-4
doi:

Substances chimiques

Taxoids 0
Antineoplastic Agents 0
taxane 1605-68-1
Bridged-Ring Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

304

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Flatters SJL, Dougherty PM, Colvin LA (2017) Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review. Br J Anaesth 119:737–749
pubmed: 29121279 doi: 10.1093/bja/aex229
Park SB, Goldstein D, Krishnan AV, Lin CSY, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437
pubmed: 24590861 doi: 10.3322/caac.21204
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155:2461–2470
pubmed: 25261162 doi: 10.1016/j.pain.2014.09.020
Rivera DR, Ganz PA, Weyrich MS, Bandos H, Melnikow J (2018) Chemotherapy-associated peripheral neuropathy in patients with early-stage breast cancer: a systematic review. J Natl Cancer Inst 110:djx140
pubmed: 28954296 doi: 10.1093/jnci/djx140
Osumi M, Sumitani M, Abe H, Otake Y, Kumagaya S-I, Morioka S (2019) Kinematic evaluation for impairment of skilled hand function in chemotherapy-induced peripheral neuropathy. J Hand Ther 32:41–47
pubmed: 29042161 doi: 10.1016/j.jht.2017.06.003
Zanville NR, Nudelman KNH, Smith DJ et al (2016) Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer 24:4779–4789
pubmed: 27470258 pmcid: 5031751 doi: 10.1007/s00520-016-3329-5
Mahfouz FM, Li T, Joda M et al (2024) Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity. J Neurol Sci 1(457):122862
doi: 10.1016/j.jns.2023.122862
Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56:323–331
pubmed: 17846553 doi: 10.1097/01.NNR.0000289503.22414.79
Tuğral A, Arıbaş Z, Akyol M, Bakar Y (2023) Assessment of sensorimotor and strength related function of breast cancer patients during systemic drug therapy: a prospective observational study. BMC Cancer 23:981
pubmed: 37838686 pmcid: 10576361 doi: 10.1186/s12885-023-11494-x
McCrary JM, Goldstein D, Boyle F et al (2017) Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer 25:3485–3493
pubmed: 28589310 doi: 10.1007/s00520-017-3772-y
Stoller S, Capozza S, Alberti P, Lustberg M, Kleckner IR (2023) Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN). Support Care Cancer 31:293
pubmed: 37086308 doi: 10.1007/s00520-023-07734-2
Guo S, Han W, Wang P, Xue Wang X, Fang X (2023) Effects of exercise on chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis. J Cancer Surviv 17:318–331
pubmed: 35149899 doi: 10.1007/s11764-022-01182-3
Tamburin S, Park SB, Schenone A et al (2022) Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. Crit Rev Oncol Hematol 171:103575
pubmed: 34968623 doi: 10.1016/j.critrevonc.2021.103575
Vanbellingen T, Nyffeler T, Nigg J et al (2017) Home based training for dexterity in Parkinson’s disease: a randomized controlled trial. Parkinsonism Relat Disord 41:92–98
pubmed: 28578819 doi: 10.1016/j.parkreldis.2017.05.021
Winstein C, Wolf S, Dromerick A et al (2016) Effect of a task-oriented rehabilitation program on upper extremity recovery following motor stroke: the ICARE randomized clinical trial. JAMA 9(315):571–581
doi: 10.1001/jama.2016.0276
Che Bakri NA, Kwasnicki RM, Khan N et al (2023) Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis. Ann Surg 277:572–580
pubmed: 35946806 doi: 10.1097/SLA.0000000000005671
Leysen L, Beckwée D, Nijs J, Pas R, Bilterys T, Vermeir S, Adriaenssens N (2017) Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer 25:3607–3643
pubmed: 28799015 doi: 10.1007/s00520-017-3824-3
Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F (2006) Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33:15–49
pubmed: 16473643 doi: 10.1053/j.seminoncol.2005.12.010
Shimozuma K, Ohashi Y, Takeuchi A et al (2009) Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer 17:1483–1491
pubmed: 19330359 doi: 10.1007/s00520-009-0613-7
Amano T, Shimada Y, Nishina T et al (2012) Prospective validation of patient neurotoxicity questionnaire (PNQ) for assessment of oxaliplatin neurotoxicity: CSP-HOR 16. Ann Oncol 23:ix512–ix513
doi: 10.1016/S0923-7534(20)34137-5
Kennedy CA, Beaton DE, Smith P, Eerd DV, Tang K, Inrig T, Hogg-Johnson S, Linton D, Couban R (2013) Measurement properties of the QuickDASH (disabilities of the arm, shoulder and hand) outcome measure and cross-cultural adaptations of the QuickDASH: a systematic review. Qual Life Res 22:2509–2547
pubmed: 23479209 doi: 10.1007/s11136-013-0362-4
Staples LG, Dear BF, Gandy M et al (2019) Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: the PHQ-2, GAD-2, and K-6. Gen Hosp Psychiatry 56:13–18
pubmed: 30508772 doi: 10.1016/j.genhosppsych.2018.11.003
Raji P, Ansari NN, Naghdi S, Forogh B, Hasson S (2014) Relationship between Semmes-Weinstein Monofilaments perception test and sensory nerve conduction studies in Carpal Tunnel Syndrome. Neuro Rehabilitation 35:543–545
pubmed: 25238864
O’Brien T, Karem J (2014) An initial evaluation of a proof-of-concept 128-Hz electronic tuning fork in the detection of peripheral neuropathy. J Am Podiatr Med Assoc 104:134–140
pubmed: 24725032 doi: 10.7547/0003-0538-104.2.134
Schmidt SL, Oliveira RM, Rocha FR, Abreu-Villaça Y (2000) Influences of handedness and gender on the grooved pegboard test. Brain Cogn 44:445–454
pubmed: 11104536 doi: 10.1006/brcg.1999.1204
Omori M, Shibuya S, Nakajima T et al (2018) Hand dexterity impairment in patients with cervical myelopathy: a new quantitative assessment using a natural prehension movement. Behav Neurol 2018:5138234
pubmed: 30073036 pmcid: 6057419 doi: 10.1155/2018/5138234
Kitai K, Odagiri M, Yamauchi R, Kodama T (2021) Evaluation of intervention effectiveness of sensory compensatory training with tactile discrimination feedback on sensorimotor dysfunction of the hand after stroke. Brain Sci 11:1314
pubmed: 34679379 pmcid: 8534145 doi: 10.3390/brainsci11101314
Berquin AD, Lijesevic V, Blond S, Plaghki L (2010) An adaptive procedure for routine measurement of light-touch sensitivity threshold. Muscle Nerve 42:328–338
pubmed: 20665509 doi: 10.1002/mus.21689
Bear-Lehman J, Abreu BC (1989) Evaluating the hand: issues in reliability and validity. Phys Ther 69:1025–1033
pubmed: 2685841 doi: 10.1093/ptj/69.12.1025
Dikmen SS, Heaton RK, Grant I, Temkin NR (1999) Test-retest reliability and practice effects of expanded Halstead-Reitan neuropsychological test battery. J Int Neuropsychol Soc 5:346–356
pubmed: 10349297 doi: 10.1017/S1355617799544056
Harrell FE (2001) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis, 1st edn. Springer-Verlag, New York, NY
doi: 10.1007/978-1-4757-3462-1
Mizrahi D, Park SB, Li T et al (2021) Hemoglobin, body mass index, and age as risk factors for paclitaxel and oxaliplatin-induced peripheral neuropathy. JAMA Netw Open 4:e2036695
pubmed: 33587134 pmcid: 7885037 doi: 10.1001/jamanetworkopen.2020.36695
Zhi WI, Chen P, Kwon A et al (2019) Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 178:587–595
pubmed: 31456070 pmcid: 6819268 doi: 10.1007/s10549-019-05416-4
Ghoreishi Z, Keshavarz S, Jafarabadi MA, Fathifar Z, Goodman KA, Esfahani A (2018) Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer. BMC Cancer 18:958
pubmed: 30290775 pmcid: 6173931 doi: 10.1186/s12885-018-4869-5
Tanabe A, Kanai M, Horimatsu T et al (2018) Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study. Support Care Cancer 26:2397–2405
doi: 10.1007/s00520-018-4070-z
Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561–1565
pubmed: 6103535 pmcid: 348536 doi: 10.1073/pnas.77.3.1561
Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667
pubmed: 423966 doi: 10.1038/277665a0
Sahenk Z, Barohn R, New P, Mendell JR (1994) Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51:726–729
pubmed: 7912506 doi: 10.1001/archneur.1994.00540190110024
Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81:772–781
pubmed: 28486769 pmcid: 5656281 doi: 10.1002/ana.24951
Baur B, Fürholzer W, Marquardt C, Hermsdörfer J (2009) Auditory grip force feedback in the treatment of Writer’s cramp. J Hand Ther 22:163–70 (quiz 171)
pubmed: 19188043 doi: 10.1016/j.jht.2008.11.001
Nowak DA, Glasauer S, Hermsdörfer J (2013) Force control in object manipulation–a model for the study of sensorimotor control strategies. Neurosci Biobehav Rev 37:1578–1586
pubmed: 23791788 doi: 10.1016/j.neubiorev.2013.06.003
Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004–1014
pubmed: 7885406 doi: 10.1056/NEJM199504133321507
Ma Y, He B, Jiang M, Yang Y, Wang C, Huang C, Han L (2020) Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis. Int J Nurs Stud 111:103707
pubmed: 32920423 doi: 10.1016/j.ijnurstu.2020.103707
Huang J, Chan PSF, Lok V et al (2021) Global incidence and mortality of breast cancer: a trend analysis. Aging (Albany NY) 13:5748–5803
doi: 10.18632/aging.202502

Auteurs

Masahiro Manfuku (M)

Department of Rehabilitation, Breast Care Sensyu Clinic, Osaka, Japan.

Junichiro Inoue (J)

Division of Rehabilitation Medicine, Kobe University Hospital International Clinical Cancer Research Center, Hyogo, Japan.

Nobuki Yamanaka (N)

Department of Rehabilitation Medicine, Nara Medical University, Nara, Japan.

Hiroe Kanamori (H)

Department of Breast Surgery, Breast Care Sensyu Clinic, Osaka, Japan.

Kazuhiro Sumiyoshi (K)

Department of Breast Surgery, Breast Care Sensyu Clinic, Osaka, Japan.

Michihiro Osumi (M)

Graduate School of Health Science, Kio University, 4-2-2 Umaminaka, Koryo-Cho, Kitakatsuragi-Gun, Nara, 635-0832, Japan. m.ohsumi@kio.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH